News and features

Articles

Showing 11 - 20 of 57

News & Analysis

Designing around patent is considered legitimate

13 December 2023 by DPS Parmar

It is common to find competitive inventors to work on the uncovered aspect of a patent claim and design around it to escape the sword of infringement.

News & Analysis

LexOrbis Strengthens its IP Footprint with Chennai Expansion

04 December 2023 by LexOrbis - India

LexOrbis is delighted to announce the opening of its new office in Chennai, India.

News & Analysis

Effects of the Draft Patent Rules, 2023 on Pharma Industry

30 November 2023 by Manisha Singh (Partner) & Harshini A. (Trainee Associate)

A couple of months back, the Ministry of Commerce and Industry published the Draft Patents (Amendment) Rules,2023, with various changes to the rules, regulations and fees, which welcomed suggestions and objections from the public.

News & Analysis

IP Courts Revisiting the Scope of Claims Amendment

20 November 2023 by LexOrbis : Neha Ruhela (Senior Associate)

After the milestone verdict of the Delhi High Court in Allergan v Controller (2023:DHC:515), now it is time for patent strategists to rejoice over landmark judgments of the Madras High Court, including Starpharma Pty Ltd. v Controller (2023/MHC/4638) that provide similar liberal interpretations of amendment of claims under Section 59 of the Patents Act, 1970.

News & Analysis

Relooking at the reach of Section 3(d) of the Indian Patents Act, 1970 after ‘Novozymes’ Case

30 October 2023 by LexOrbis - DPS Parmar

Section 3(d) of the Indian Patents Act, 1970 was never so controversial till the insertion of an amendment in 2005, which states that “the mere discovery of a new form of a known substance which does not result in the enhancement of the known efficacy of that substance".

News & Analysis

Analysing the Department of Biotechnology (DBT) Intellectual Property Guidelines 2023

16 October 2023 by LexOrbis - India : Manisha Singh (Partner) & Shikha Singh (Managing Associate)

With increasing awareness of securing intellectual property rights and deriving value from them, the commercialisation of patents is an important aspect.

News & Analysis

Discovery vs Mere Discovery under Patent Law

11 September 2023 by LexOrbis - DPS Parmar

The term discovery is used in Section 3 (c) and Section 3 (d) of the Patents Act 1970, but it is not defined under the act and the Patent Rules 2003

News & Analysis

Civil Court Lacks Jurisdiction to Determine Validity of Registered Plant Variety

03 August 2023 by LexOrbis - India : Manisha Singh (Partner) & Neha Ruhela (Senior Associate)

In India, the protection of plant varieties is outside the purview of the patent system.

News & Analysis

mRNA Vaccines: A Breakthrough Technology

11 July 2023 by LexOrbis - India: Manisha Singh (Partner) & Vaneet Kaur (Senior Associate)

RNA molecules have been utilized as therapeutic and research tools for more than two decades, with the usage ranging from in vitro transcribed (IVT) mRNA, small interference RNA (siRNA), RNA aptamers, riboswitches, and antisense RNA to the recently developed mRNA vaccines.

News & Analysis

Patenting Molecular Diagnostics

17 May 2023 by LexOrbis - DPS Parmar

The patent eligibility in every jurisdiction differs in content and form. It perhaps finds its justification in the stage of development the country is placed in relation to inventions of new technology or its adoption by the state technology groups.